Malignant Intracranial Neoplasm — Trials

Malignant Intracranial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

637 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (100)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05076513	Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma	active not recruiting	Early Phase 1	42	Nader SanaiOTHER	1	Mar 9, 2026	clinicaltrials
NCT03893487	Fimepinostat in Treating Brain Tumors in Children and Young Adults(PNOC016)	active not recruiting	Early Phase 1	30	Sabine Mueller, MD, PhDOTHER	2	Jul 11, 2025	clinicaltrials